Comparison of scar treatment response and recovery of skin reaction after ablative fractional laser according to topical application of stem cell in atrophic scar patients
- Conditions
- Diseases of the skin and subcutaneous tissue
- Registration Number
- KCT0003718
- Lead Sponsor
- Samsung Medical Center
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 13
Subjects who visited our dermatology clinic and were diagnosed with atrophic scar on those face
- Adults from 19 to 65 years of age
- Subjects who voluntarily signed a written consent with hearing the purpose and contents of the examination before the examination
- Subjects who can be followed up during the test
- Subjects who disagree or do not fill out a consent form
- Subjects who are currently confirmed as pregnant (do not conduct pregnancy tests separately).
- Subjects who are currently lactating
- Subjects who have infectious skin disease on face
- Subjects who take retinoid drugs (Isotretinoin, acitretin, alitretinoin, etc.) within 1 month of the test
- Subjects who have serious systemic or chronic diseases (hypertension, diabetes, etc.)
- In case of difficulty in measurement due to other skin lesions on the test site
- Subjects who are exposed to cosmetics, medicines or daily light exposure or are allergic to them
- Subjects who are applying other drugs to the face
- Subjects who are judged that it is difficult to be included to the research by the judgment of the research examiner
Study & Design
- Study Type
- Interventional Study
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Difference of erythema index between both sides of face;Improvement of scar;Adverse reaction after use of test agent
- Secondary Outcome Measures
Name Time Method Subject's satisfaction with laser treatment measured with a VAS scale